tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

HealthEquity price target raised to $110 from $109 at RBC Capital

RBC Capital raised the firm’s price target on HealthEquity (HQY) to $110 from $109 and keeps an Outperform rating on the shares. The company delivered a strong beat and raise, largely due to improvements in gross margin, and the firm sees tailwinds for the company as it both de-risks its HSA cash portfolio with additional forward contracts in FY26, setting up yield improvement in FY27 and beyond, the analyst tells investors in a research note. RBC further cites HealthEquity reducing interest rate sensitivity and leveraging AI to further strengthen its Service gross margins.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1